Correction to: Survival from breast cancer in women with a BRCA2 mutation by treatment

D Gareth Evans¹, Kelly-Anne Phillips^{2

3

4}, Roger L Milne^{4

5

6}, Robert Fruscio⁷, Cezary Cybulski⁸, Jacek Gronwald⁸, Jan Lubinski⁸, Tomasz Huzarski^{8

9}, Zerin Hyder¹, Claire Forde¹, Kelly Metcalfe¹⁰, Leigha Senter¹¹, Jeffrey Weitzel¹², Nadine Tung¹³, Dana Zakalik¹⁴, Maria Ekholm¹⁵, Ping Sun¹⁰, Steven A Narod¹⁶; kConFab Investigators, Polish Hereditary Breast Cancer Consortium, Hereditary Breast Cancer Clinical Study Group

Collaborators, Affiliations

Collaborators

kConFab Investigators, Polish Hereditary Breast Cancer Consortium, Hereditary Breast Cancer Clinical Study Group:
Maria Błasińska-Morawiec, Maria Chosia, Kazimierz Drosik, Sylwia Gozdecka-Grodecka, Stanisław Goźdź, Ewa Grzybowska, Arkadiusz Jeziorski, Aldona Karczewska, Radzisław Kordek, Agnieszka Synowiec, Beata Kozak-Klonowska, Katarzyna Lamperska, Dariusz Lange, Andrzej Mackiewicz, Jerzy Władysław Mituś, Stanislas Niepsuj, Oleg Oszurek, Karol Gugała, Zbigniew Morawiec, Tomasz Mierzwa, Michał Posmyk, Janusz Ryś, Cezary Szczylik, Michał Uciński, Krzysztof Urbański, Bernard Waśko, Piotr Wandzel, Michael Friedlander, Sue Anne McLachlan, Stephanie Nesci, Sandra Picken, Sarah O'Connor, Lucy Stanhope, Andrea Eisen, Kevin Sweet, Raymond Kim, William Foulkes, Pal Moller, Susan Neuhausen, Carey Cullinane, Charis Eng, Peter Ainsworth, Fergus Couch, Christian Singer, Beth Karlan, Wendy McKinnon, Marie Wood

Affiliations

¹ Genomic Medicine, Manchester Academic Health Science Centre, The University of Manchester, Manchester, UK.
² Sir Peter MacCallum Department of Oncology, University of Melbourne, Parkville, Australia.
³ Department of Medical Oncology, Peter MacCallum Cancer Centre, Melbourne, Australia.
⁴ Centre for Epidemiology and Biostatistics, Melbourne School of Population and Global Health, The University of Melbourne, Melbourne, VIC, Australia.
⁵ Precision Medicine, School of Clinical Sciences at Monash Health, Monash University, Clayton, VIC, Australia.
⁶ Cancer Epidemiology Division, Cancer Council Victoria, Melbourne, VIC, Australia.
⁷ Department of Medicine and Surgery, University of Milan-Bicocca, Milan, Italy.
⁸ Department of Genetics and Pathology, International Hereditary Cancer Center, Pomeranian Medical University, Szczecin, Poland.
⁹ University of Zielona Góra, Zielona Góra, Poland.
¹⁰ Women's College Research Institute, Women's College Hospital, Toronto, ON, Canada.
¹¹ Division of Human Genetics, the Ohio State University Medical Center, Comprehensive Cancer Center, Columbus, OH, USA.
¹² Division of Clinical Cancer Genomics, Department of Population Sciences, City of Hope, Duarte, CA, USA.
¹³ Beth Israel Deaconess Medical Center, Boston, MA, USA.
¹⁴ Nancy and James Grosfeld Cancer Genetics Center, Beaumont Cancer Institute, Beaumont Health, Royal Oak, MI, USA.
¹⁵ Manchester Academic Health Science Centre, Department of Medical Oncology, The Christie, Manchester, UK.
¹⁶ Women's College Research Institute, Women's College Hospital, Toronto, ON, Canada. steven.narod@wchospital.ca.

PMID: 36639528
PMCID: PMC9938238
DOI: 10.1038/s41416-022-02130-9

Published Erratum

Correction to: Survival from breast cancer in women with a BRCA2 mutation by treatment

D Gareth Evans et al. Br J Cancer. 2023 Feb.

. 2023 Feb;128(4):703.

doi: 10.1038/s41416-022-02130-9.

Authors

Collaborators

kConFab Investigators, Polish Hereditary Breast Cancer Consortium, Hereditary Breast Cancer Clinical Study Group:
Maria Błasińska-Morawiec, Maria Chosia, Kazimierz Drosik, Sylwia Gozdecka-Grodecka, Stanisław Goźdź, Ewa Grzybowska, Arkadiusz Jeziorski, Aldona Karczewska, Radzisław Kordek, Agnieszka Synowiec, Beata Kozak-Klonowska, Katarzyna Lamperska, Dariusz Lange, Andrzej Mackiewicz, Jerzy Władysław Mituś, Stanislas Niepsuj, Oleg Oszurek, Karol Gugała, Zbigniew Morawiec, Tomasz Mierzwa, Michał Posmyk, Janusz Ryś, Cezary Szczylik, Michał Uciński, Krzysztof Urbański, Bernard Waśko, Piotr Wandzel, Michael Friedlander, Sue Anne McLachlan, Stephanie Nesci, Sandra Picken, Sarah O'Connor, Lucy Stanhope, Andrea Eisen, Kevin Sweet, Raymond Kim, William Foulkes, Pal Moller, Susan Neuhausen, Carey Cullinane, Charis Eng, Peter Ainsworth, Fergus Couch, Christian Singer, Beth Karlan, Wendy McKinnon, Marie Wood

Affiliations

¹ Genomic Medicine, Manchester Academic Health Science Centre, The University of Manchester, Manchester, UK.
² Sir Peter MacCallum Department of Oncology, University of Melbourne, Parkville, Australia.
³ Department of Medical Oncology, Peter MacCallum Cancer Centre, Melbourne, Australia.
⁴ Centre for Epidemiology and Biostatistics, Melbourne School of Population and Global Health, The University of Melbourne, Melbourne, VIC, Australia.
⁵ Precision Medicine, School of Clinical Sciences at Monash Health, Monash University, Clayton, VIC, Australia.
⁶ Cancer Epidemiology Division, Cancer Council Victoria, Melbourne, VIC, Australia.
⁷ Department of Medicine and Surgery, University of Milan-Bicocca, Milan, Italy.
⁸ Department of Genetics and Pathology, International Hereditary Cancer Center, Pomeranian Medical University, Szczecin, Poland.
⁹ University of Zielona Góra, Zielona Góra, Poland.
¹⁰ Women's College Research Institute, Women's College Hospital, Toronto, ON, Canada.
¹¹ Division of Human Genetics, the Ohio State University Medical Center, Comprehensive Cancer Center, Columbus, OH, USA.
¹² Division of Clinical Cancer Genomics, Department of Population Sciences, City of Hope, Duarte, CA, USA.
¹³ Beth Israel Deaconess Medical Center, Boston, MA, USA.
¹⁴ Nancy and James Grosfeld Cancer Genetics Center, Beaumont Cancer Institute, Beaumont Health, Royal Oak, MI, USA.
¹⁵ Manchester Academic Health Science Centre, Department of Medical Oncology, The Christie, Manchester, UK.
¹⁶ Women's College Research Institute, Women's College Hospital, Toronto, ON, Canada. steven.narod@wchospital.ca.

PMID: 36639528
PMCID: PMC9938238
DOI: 10.1038/s41416-022-02130-9

No abstract available

PubMed Disclaimer

Erratum for

Survival from breast cancer in women with a BRCA2 mutation by treatment.
Evans DG, Phillips KA, Milne RL, Fruscio R, Cybulski C, Gronwald J, Lubinski J, Huzarski T, Hyder Z, Forde C, Metcalfe K, Senter L, Weitzel J, Tung N, Zakalik D, Ekholm M, Sun P, Narod SA; kConFab Investigators, Polish Hereditary Breast Cancer Consortium, Hereditary Breast Cancer Clinical Study Group. Evans DG, et al. Br J Cancer. 2021 Apr;124(9):1524-1532. doi: 10.1038/s41416-020-01164-1. Epub 2021 Feb 18. Br J Cancer. 2021. PMID: 33597716 Free PMC article.

Publication types

Actions

LinkOut - more resources

Full Text Sources
Miscellaneous
- NCI CPTAC Assay Portal

Save citation to file

Email citation

Add to Collections

Add to My Bibliography

Your saved search

Create a file for external citation management software

Your RSS Feed

Correction to: Survival from breast cancer in women with a BRCA2 mutation by treatment

Collaborators

Affiliations

Correction to: Survival from breast cancer in women with a BRCA2 mutation by treatment

Authors

Collaborators

Affiliations

Erratum for

Publication types

LinkOut - more resources

Full Text Sources

Miscellaneous